Delivery Order SPE2DB22D2206-SPE2DB24FGK89
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,914.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 30 mg kits. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 and in effect through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract, valued at $2,648.30, to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Sandostatin LAR Depot 20 mg kits. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,093.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 10 mg pharmaceutical kits. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,017.02 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Sandostatin LAR Depot 30 mg kits. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00, for the supply of pharmaceutical products and medical supplies to DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,389,740 units of Sandostatin LAR Depot 20 mg pharmaceutical kits. The $9,741.90 firm fixed price contract has an ultimate completion date of April 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,631.34 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Sandostatin LAR Depot 10 mg kits. This delivery order contract has an ultimate completion date of April 3, 2024 and was awarded on April 2, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 30 mg kits of the pharmaceutical product Sandostatin LAR Depot. The $6,562.82 award has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA, which serves as the primary vehicle for the company to deliver...
- The Defense Logistics Agency awarded a $14,833.72 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits under a firm fixed price contract. The award, made on June 26, 2025, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This award involved no set-aside designation and was competitively awarded...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $7,829.04 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of Sandostatin LAR Depot 30 MG KTS, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,648.30 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of Sandostatin LAR Depot, a specialty pharmaceutical product, with a completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGK89Delivery Order
The Defense Logistics Agency (DLA) awarded a $6,562.82 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide Sandostatin LAR Depot 30 mg kits. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to supply a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this IDC, which serves as the primary contract vehicle for the company to deliver medications and healthcare materials to military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 4/2/24 |